Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy
NCT01345006
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class
Conditions
Stargardt's Macular Dystrophy
Interventions
BIOLOGICAL:
MA09-hRPE
Sponsor
Astellas Institute for Regenerative Medicine